Jan 16 (Reuters) – U.S. private equity firm Hellman & Friedman is in early stage talks for a potential sale of medical devices maker Cordis, seeking a value of over $9 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
Reuters could not immediately verify the report.
(Reporting by Carlos Méndez in Mexico City, editing by Chris Reese)
